Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Claritas Pharmaceuticals, Inc. (V.CLA) had Return on Tangible Equity of 2.59% for the most recently reported fiscal quarter, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
-2.42M |
|
-- |
|
-- |
|
-- |
|
-2.64M |
|
-- |
|
-2.42M |
|
-2.42M |
|
-2.42M |
|
-2.42M |
|
-2.42M |
|
-2.42M |
|
-2.64M |
|
2.66M |
|
6.55M |
|
6.55M |
|
-0.26 |
|
-0.26 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
80.24M |
|
-- |
|
-- |
|
-- |
|
96.22M |
|
-15.98M |
|
-93.74M |
|
-15.98M |
|
6.66M |
|
| Cash Flow Statement Financials | |
-1.66M |
|
-- |
|
-0.63M |
|
4.66M |
|
2.37M |
|
-2.30M |
|
0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.35 |
|
-- |
|
-- |
|
5.43 |
|
-1.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
15.16% |
|
|
Return on Tangible Equity |
2.59% |
-3.02% |
|
-67.13% |
|
-2.40 |
|
-0.25 |
|
-0.25 |
|